Evidence-based case report the prevention and management of postherpetic neuralgia with emphasis on interventional procedures

Regional Anesthesia and Pain Medicine

Volumn 34, Issue 5, 2009, Pages 514-521

  Benzon, Honorio T ^a   Chekka, Kiran ^a   Darnule, Amit ^a   Chung, Brian ^a   Wille, Oscar ^a   Malik, Khalid ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALCOHOL; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; BUPIVACAINE; CAPSAICIN; DESIPRAMINE; DOXEPIN; DULOXETINE; FENTANYL; GABAPENTIN; LIDOCAINE; MEMANTINE; METHADONE; METHYLPREDNISOLONE; NORTRIPTYLINE; OPIATE; OXYCODONE; PREDNISOLONE; PREGABALIN; STEROID; TRAMADOL;

ACUTE DISEASE; AGED; ALLODYNIA; ANESTHESIOLOGICAL TECHNIQUES; ANOREXIA; ARTICLE; ATAXIA; BURNING SENSATION; CASE REPORT; CLASSIFICATION ALGORITHM; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; DERMATOME; DISEASE CONTROL; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOCRINE DISEASE; EPIDURAL ANESTHESIA; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; HERPES ZOSTER; HOSPITAL DISCHARGE; HUMAN; INFORMATION SERVICE; INTERVENTION STUDY; LEG SWELLING; LIBIDO DISORDER; LOCAL ANESTHESIA; MONOTHERAPY; NAUSEA AND VOMITING; NERVE BLOCK; NEUROLOGIC EXAMINATION; PAIN ASSESSMENT; PAIN CLINIC; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QT PROLONGATION; SEDATION; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SOMNOLENCE; SPINAL CORD STIMULATION; TACHYCARDIA; TREATMENT RESPONSE; URINE RETENTION; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADMINISTRATION, CUTANEOUS; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANTICONVULSANTS; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; ELECTRIC STIMULATION THERAPY; ETHANOL; EVIDENCE-BASED MEDICINE; FEMALE; HERPES ZOSTER VACCINE; HUMANS; INJECTIONS, SPINAL; NERVE BLOCK; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; STEROIDS; TREATMENT OUTCOME;

EID: 74549215077     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/AAP.0b013e3181b137bd     Document Type: Article

References (75)

1. Moore DC. Spinal (subarachnoid) block with absolute alcohol. In: Moore DC. Regional Block. A Handbook for Use in the Clinical Practice of Medicine and Surgery. 4th ed. Springfield, IL: Charles C. Thomas; 1965:485-490.
2. van Tulder M, Malmivaara A, Esmail R, Koes B. Exercise therapy for low back pain. Spine. 2000;25:2784-2796.
3. Niemisto L, Kalso E, Malmivaara A, Seitsalso S, Hurri H. Radiofrequency denervation for neck and back pain: a systemic review within the framework of the Cochrane collaboration back review group. Spine. 2003;28:1877-1888.
4. Malik K, Benzon HT. Radiofrequency applications to dorsal root ganglia: a literature review. Anesthesiology. 2008;109:527-542.
5. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995;155:1605-1609.
6. Hope-Simpson RE. Postherpetic neuralgia. J Royal Coll Gen Pract. 1975;25:571-575.
7. Gnann J. Vaccination to prevent herpes zoster in older adults. J Pain. 2008;9:S31-S36.
8. Balfour HH, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, et al; and the Burroughs Wellcome Collaborative Acyclovir Study Group. Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med. 1983;308:1448-1453.
9. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994;330:896-900.
10. Tyring SK, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, et al. Famciclovir for the treatment of acute herpes zoster: effects on disease and postherpetic neuralgia. Ann Int Med. 1995;123:89-96.
11. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster. Arch Fam Med. 2000;9:863-869.
12. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44:S1-S26.
13. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al, for the Shingles Prevention Study Group. Avaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;325:2271-2284.
14. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 1997;13:327-331.
15. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med. 2004;454-461.
16. Ali NM. Does sympathetic ganglionic block prevent postherpetic neuralgia? Literature review. Reg Anesth. 1995;20:227-233.
17. Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain. 2000;87:121-129.
18. Tenicella R, Lovasik D, Eaglstein W. Treatment of herpes zoster with sympathetic blocks. Clin J Pain. 1985;1:63-67.
19. Rutgers MJ, Dirksen R. The prevention of postherpetic neuralgia: a retrospective review of patients treated in the acute phase of herpes zoster. Br J Clin Pract. 1988;42:412-414.
20. Riopelle JM, Naraghi M, Grush KP. Chronic neuralgia incidence following local anesthetic and steroid for relief of pain secondary to herpes zoster. Arch Dermatol. 1984;120:747-750.
21. Yanagida H, Suwa K, Corssen G. No prophylactic effect of early sympathetic blockade on postherpetic neuralgia. Anesthesiology. 1987;66:73-76.
22. Hardy D. Relief of pain in acute herpes zoster by nerve blocks and possible prevention of post-herpetic neuralgia. Can J Anaesth. 2005;52:186-190.
23. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth. 1993;18:277-282.
24. Schmader KE, Dworkin RH. Natural history and treatment of herpes zoster. J Pain. 2008;9:S3-S9.
25. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al. Prevention of postherpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand. 2000;44:910-918.
26. van Wijck AJM, Opstelten W, Moons KGM, van Essen GA, Stolker RJ, Kalkman CJ, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomized controlled trial. Lancet. 2006;367:219-224.
27. Hwang SM, Kang YC, Lee YB, Yoon KB, Ahn SK, Choi EH. The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol. 1999;135:1359-1364.
28. Ahn HJ, Lim HK, Lee YB, Hwang SM, Lee WS, Ahn SK, et al. The effects of famciclovir and epidural blockade in the treatment of herpes zoster. J Dermatol. 2001;28:208-216.
29. Dureja GP, Bhalla AP. Multimodality regimen for the management of postherpetic neuralgia. Pain Clin. 1992;5:15-19.
30. Catala E, Ferrandiz M, Aliaga L, Serra R, Castro MA, Villar LJM. Intravenous lidocaine compared with sympathetic blocks as treatment for post-herpetic neuralgia. Pain Clin. 1994;7:205-210.
31. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka N, Yodono M, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000;343:1514-1519.
32. Kikucki A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med. 1999;24:287-293.
33. Benzon HT, Gissen AJ, Strichartz GR, Avram MJ, Covino BG. The effect of polyethylene glycol on mammalian nerve impulses. Anesth Analg. 1987;66:553-559.
34. Meglio M, Cioni B, Prezioso A, Talamonti G. Spinal cord stimulation in the treatment of postherpetic pain. Acta Neurochir Suppl (Wien). 1989;46:65-66.
35. Sanchez-Ledesma MJ, Garcia-March G, Diaz-CascajoP, Gomez-Moreta J, Broseta J. Spinal cord stimulation in deafferentation pain. Stereotact Funct Neurosurg. 1989;53:40-45.
36. Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery. 2006;58:481-496.
37. Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg. 2002;94:694-700.
38. Lauretti GR, Trevelin WR, Frade LP, Lima CPR. Spinal alcohol neurolysis for intractable thoracic postherpetic neuralgia after test bupivacaine spinal analgesia. Anesthesiology. 2004;101:244-247.
39. Matsuki K, Kato Y, Ichiyanagi K. Progressive changes in the concentration of ethyl alcohol in the human and canine subarachnoid spaces. Anesthesiology. 1972;36:617-621.
40. Cousins MJ. Chronic pain and neurolytic neural blockade. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1988:1053-1062.
41. Benzon HT. Complications associated with neurolytic blocks. In: Neal JM, Rathmell JP, eds. Complications in Regional Anesthesia and Pain Medicine. Philadelphia: Saunders Elsevier; 2007:273-283.
42. Malik K, Benzon HT. Pulsed radiofrequency: a critical review of its efficacy. Anaesth Intensive Care. 2007;35:863-873.
43. Wu CL, Raja SN. An update on the treatment of postherpetic neuralgia. J Pain. 2008;9:S19-S30.
44. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2:e164.
45. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.
46. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomized double-blind, placebo-controlled study. Pain. 2001;94:215-224.
47. Dworkin RH, Corbin AE, Young JP, Sharma U, LaMoreaux L, Bockbrader H, et al. Pregabalin for the treatment of postherpetic neuralgia. Neurology. 2003;60:1274-1283.
48. Sabatowski R, Galvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, et al. The 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004;109:26-35.
49. Freynhagen R, Strojek K, Griesling T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens. Pain. 2005;115:254-263.
50. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith I, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32:671-673.
51. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 1988;38:1427-1432.
52. Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smoller B, Gracely RH, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990;47:305-312.
53. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia. A randomized, double-blind crossover trial. Pain. 1992;48:29-36.
54. Raja SN, Haythornthwaite JA, Papagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59:1015-1021.
55. Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment response in antidepressant naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain. 2005;6:741-746.
56. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998;51:1166-1171.
57. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837-1841.
58. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized double-blind, placebo-controlled trial. Pain. 2003;104:323-331.
59. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain: an evidence-based proposal. Pain. 2005;118:289-305.
60. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324-1334.
61. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024-1028.
62. Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage. 1999;17:429-433.
63. Wallace MS, Magnuson S, Ridgeway B. Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med. 2000;25:459-467.
64. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia. Pain. 1996;65:39-44.
65. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80:533-538.
66. Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, Hueppe M, et al. Efficacy of lidocaine patch 5% in the treatment of focal neuropathic pain syndromes: a randomized double-blind placebo-controlled study. Pain. 2003;106:151-158.
67. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18:297-301.
68. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Miilikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol. 1989;21:265-270.
69. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993;15:510-526.
70. Eide PK, Jorum E, Stubhaug A, Bremmes J, Breivik H. Relief of postherpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347-354.
71. Eide PK, Stubhaug A, Oye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of postherpetic neuralgia. Pain. 1995;61:221-228.
72. Hoffman V, Coppejans H, Vercauteren M, Adriaensen H. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain. 1994;10:240-242.
73. Eisenberg E, Kleiser A, Dortort A, Haim T, Yarnitsky D. The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind placebo-controlled study. Eur J Pain. 1998;2:321-327.
74. Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology. 2002;96:1053-1061.
75. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia. Neurology. 2004;63:959-965.